BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Analyst: Roche May Drop Taspoglutide Diabetes Drug

  June 28, 2010

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim Corporation Announces Results of Phase III Data Showing That Linagliptin Significantly Lowered Blood Glucose with an Excellent Safety and Tolerability Profile

  June 28, 2010

   · 

  1 min read
• Drug Development

  BioAlliance Pharma Presents Phase III Results with Loramyc(R) (Miconazole Lauriad(R)) and Ongoing Phase II Trial with Clonidine Lauriad(R)

  June 28, 2010

   · 

  1 min read
• BioMidwest

  Phylogeny, Inc. Shares in $1M Third Frontier Grant

  June 28, 2010

   · 

  1 min read
• FDA

  FDA Panel Votes Against NDA For Boehringer Ingelheim Corporation’s ‘Female Viagra’ Flibanserin

  June 28, 2010

   · 

  1 min read
• Shire plc Named Company of the Year at Mediscience Awards

  June 28, 2010

   · 

  2 min read
• Biotech Bay

  Castlight Health Raises $60 Million to Support Commercial Rollout

  June 28, 2010

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: Oral Presentation at American Society of Clinical Oncology from Intergroup Phase III Study (CALGB 100104) Evaluates Continuous REVLIMID® in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant

  June 28, 2010

   · 

  1 min read